Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types

Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types

Despite encouraging results with immune checkpoint inhibition (ICI), a large fraction of cancer patients still does not achieve clinical benefit. Finding predictive markers in the complexity of the tumor microenvironment is a challenging task and often requires invasive procedures. In our study, we...

Full description

Bibliographic Details
Main Authors: Vinicius Araujo B. de Lima, Morten Hansen, Iben Spanggaard, Kristoffer Rohrberg, Sine Reker Hadrup, Ulrik Lassen, Inge Marie Svane
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
immune checkpoint inhibition
PBMCs
immune signature
prediction
clinical outcome
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.558248/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.558248/full

Similar Items